NMR studies of some rifamycins
Authors:
- L SantosLSL Santos
- M.A MedeirosMMM.A Medeiros
- S SantosSSS Santos
- M.C CostaMCM.C Costa
- R TavaresRTR Tavares
- M.J.M CurtoMCM.J.M Curto
- 1 May 2001
- journal article
- Published by Elsevier in Journal of Molecular Structure
- Vol. 563-564, 61-78
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Structural characterization by NMR of rifabutinol, a derivative of rifabutinMagnetic Resonance in Chemistry, 2000
- Antimicrobial Activity of RifabutinClinical Infectious Diseases, 1996
- The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessmentJournal of Antimicrobial Chemotherapy, 1993
- Recommendations on Prophylaxis and Therapy for Disseminated Mycobacterium avium Complex Disease in Patients Infected with the Human Immunodeficiency VirusNew England Journal of Medicine, 1993
- Two Controlled Trials of Rifabutin Prophylaxis against Mycobacterium avium Complex Infection in AIDSNew England Journal of Medicine, 1993
- Mechanism of inhibition of DNA-dependent RNA polymerase of Escherichia coli by rifamycinsEuropean Journal of Medicinal Chemistry, 1989
- Urinary Metabolites of Rifabutin, a New Antimycobacterial Agent, in Human VolunteersXenobiotica, 1989
- Interaction between rifabutin and human immunodeficiency virus type 1: inhibition of replication, cytopathic effect, and reverse transcriptase in vitroAntimicrobial Agents and Chemotherapy, 1988
- Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 1986
- LM 427,a new spiropiperidylrifamycin: In vitro and in vivo studies.The Journal of Antibiotics, 1983